MARKET

MRVI

MRVI

Maravai Lifesciences Holdings, Inc.
NASDAQ
7.68
-0.02
-0.26%
Pre Market: 8.01 +0.33 +4.30% 04:01 11/13 EST
OPEN
7.93
PREV CLOSE
7.70
HIGH
7.93
LOW
7.60
VOLUME
300
TURNOVER
--
52 WEEK HIGH
9.42
52 WEEK LOW
2.800
MARKET CAP
2.00B
P/E (TTM)
-17.1390
1D
5D
1M
3M
1Y
5Y
1D
Video: Nvidia slump deepens, drags down futures
TipRanks · 19h ago
Maravai LifeSciences Price Target Announced at $11.00/Share by Keybanc
Dow Jones · 21h ago
Maravai LifeSciences Raised to Overweight From Sector Weight by Keybanc
Dow Jones · 21h ago
Keybanc Upgrades Maravai LifeSciences to Overweight, Announces $11 Price Target
Benzinga · 21h ago
KeyBanc upgrades Maravai to Overweight on midterm election results
TipRanks · 23h ago
Maravai Lifesciences upgraded to Overweight from Sector Weight at KeyBanc
TipRanks · 1d ago
Weekly Report: what happened at MRVI last week (1102-1106)?
Weekly Report · 4d ago
Maravai LifeSciences Holdings Consensus Price Target Raised 11.76% to $9.69
NASDAQ · 4d ago
More
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.

Webull offers Maravai Lifesciences Holdings Inc stock information, including NASDAQ: MRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRVI stock methods without spending real money on the virtual paper trading platform.